Highlights and Quick Summary
- Retained Earnings for the quarter ending September 30, 2022 was $-1.78 Billion (a 8.36% increase compared to previous quarter)
- Year-over-year quarterly Retained Earnings increased by 23.91%
- Annual Retained Earnings for 2021 was $-1.44 Billion (a 61.68% increase from previous year)
- Annual Retained Earnings for 2020 was $-889 Million (a 101.98% increase from previous year)
- Annual Retained Earnings for 2019 was $-440 Million (a 145.22% increase from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Retained Earnings of BridgeBio Pharma, Inc.
Most recent Retained Earningsof BBIO including historical data for past 10 years.Interactive Chart of Retained Earnings of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Retained Earnings for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-1,780.56 | $-1,643.22 | $-1,633.36 | – |
| 2021 | $-1,436.97 | $-1,289.79 | $-1,133.85 | $-1,037.51 | $-1,436.97 |
| 2020 | $-888.76 | $-768.77 | $-652.92 | $-531.88 | $-888.76 |
| 2019 | – | – | $-440.03 | $-366.57 | $-440.03 |
| 2018 | – | – | – | $-179.44 | $-179.44 |
| 2017 | – | – | – | – | $-61.0 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology